Sex Differences in Mechanisms of Hypertension Associated with Obesity

Hypertension

Volumn 71, Issue 1, 2018, Pages 15-21

  Faulkner, Jessica L ^a   Belin De Chantemèle, Eric J ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; LEPTIN; SEX HORMONE;

DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTENSION; MALE; NONHUMAN; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK; SEX DIFFERENCE; SYMPATHETIC TONE; UPREGULATION; ADRENERGIC SYSTEM; AGE; COMORBIDITY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; SEX FACTOR;

AGE FACTORS; COMORBIDITY; FEMALE; HUMANS; HYPERTENSION; MALE; OBESITY; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; SEX FACTORS; SYMPATHETIC NERVOUS SYSTEM;

EID: 85038351667     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.117.09980     Document Type: Review

References (103)

1. Henry SL, Barzel B, Wood-Bradley RJ, Burke SL, Head GA, Armitage JA. Developmental origins of obesity-related hypertension. Clin Exp Pharmacol Physiol. 2012;39:799-806. doi: 10. 1111/j. 1440-1681. 2011. 05579. x.
2. Kannel WB, Zhang T, Garrison RJ. Is obesity-related hypertension less of a cardiovascular risk? The Framingham Study. Am Heart J. 1990;120:1195-1201.
3. Ogden CL, Carroll MD, Fryar CD, Flegal KM. Prevalence of obesity among adults and youth: United states, 2011-2014. NCHS Data Brief. 2015;219:1-8.
4. Yun S, Zhu BP, Black W, Brownson RC. A comparison of national estimates of obesity prevalence from the behavioral risk factor surveillance system and the National Health and Nutrition Examination Survey. Int J Obes (Lond). 2006;30:164-170. doi: 10. 1038/sj. ijo. 0803125.
5. Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in obesity among adults in the United States, 2005 to 2014. JAMA. 2016;315:2284-2291. doi: 10. 1001/jama. 2016. 6458.
6. Kramer H, Gutierrez OM, Judd SE, Muntner P, Warnock DG, Tanner RM, Panwar B, Shoham DA, McClellan W. Waist circumference, body mass index, and ESRD in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study. Am J Kidney Dis. 2016;67:62-69. doi: 10. 1053/j. ajkd. 2015. 05. 023.
7. Taylor H, Liu J, Wilson G, Golden SH, Crook E, Brunson CD, Steffes M, Johnson WD, Sung JH. Distinct component profiles and high risk among African Americans with metabolic syndrome: the Jackson Heart Study. Diabetes Care. 2008;31:1248-1253. doi: 10. 2337/dc07-1810.
8. Kanter R, Caballero B. Global gender disparities in obesity: a review. Adv Nutr. 2012;3:491-498. doi: 10. 3945/an. 112. 002063.
9. National Center for Health Statistics (US). Health, United States, 2010: With Special Feature on Death and Dying. Hyattsville, MD: National Center for Health Statistics (US); 2011.
10. Sturm R, Hattori A. Morbid obesity rates continue to rise rapidly in the United States. Int J Obes (Lond). 2013;37:889-891. doi: 10. 1038/ ijo. 2012. 159.
11. Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, Den Hond E, McCormack P, Staessen JA, O'Brien E. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension. 2005;46:156-161. doi: 10. 1161/01. HYP. 0000170138. 56903. 7a.
12. Palatini P, Reboldi G, Beilin LJ, Casiglia E, Eguchi K, Imai Y, Kario K, Ohkubo T, Pierdomenico SD, Schwartz JE, Wing L, Verdecchia P. Added predictive value of night-time blood pressure variability for cardiovascular events and mortality: the Ambulatory Blood Pressure-International Study. Hypertension. 2014;64:487-493. doi: 10. 1161/ HYPERTENSIONAHA. 114. 03694.
13. Wilsgaard T, Schirmer H, Arnesen E. Impact of body weight on blood pressure with a focus on sex differences: the Tromso Study, 1986-1995. Arch Intern Med. 2000;160:2847-2853.
14. Fujita M, Hata A. Sex and age differences in the effect of obesity on incidence of hypertension in the Japanese population: a large historical cohort study. J Am Soc Hypertens. 2014;8:64-70. doi: 10. 1016/j. jash. 2013. 08. 001.
15. de Simone G, Devereux RB, Chinali M, Roman MJ, Best LG, Welty TK, Lee ET, Howard BV; Strong Heart Study Investigators. Risk factors for arterial hypertension in adults with initial optimal blood pressure: the Strong Heart Study. Hypertension. 2006;47:162-167. doi: 10. 1161/01. HYP. 0000199103. 40105. b5.
16. Sampson UK, Edwards TL, Jahangir E, Munro H, Wariboko M, Wassef MG, Fazio S, Mensah GA, Kabagambe EK, Blot WJ, Lipworth L. Factors associated with the prevalence of hypertension in the southeastern United States: insights from 69, 211 blacks and whites in the Southern Community Cohort Study. Circ Cardiovasc Qual Outcomes. 2014;7:33-
17. doi: 10. 1161/CIRCOUTCOMES. 113. 000155.
18. Mosca L, Barrett-Connor E, Wenger NK. Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes. Circulation. 2011;124:2145-2154. doi: 10. 1161/CIRCULATIONAHA. 110. 968792.
19. Gudmundsdottir H, Hoieggen A, Stenehjem A, Waldum B, Os I. Hypertension in women: latest findings and clinical implications. Ther Adv Chronic Dis. 2012;3:137-146. doi: 10. 1177/2040622312438935.
20. Kim JK, Alley D, Seeman T, Karlamangla A, Crimmins E. Recent changes in cardiovascular risk factors among women and men. J Womens Health (Larchmt). 2006;15:734-746. doi: 10. 1089/jwh. 2006. 15. 734.
21. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995;25:305-313.
22. Chen SC, Lo TC, Chang JH, Kuo HW. Variations in aging, gender, menopause, and obesity and their effects on hypertension in Taiwan. Int J Hypertens. 2014;2014:515297. doi: 10. 1155/2014/515297.
23. Sharabi Y, Grotto I, Huerta M, Grossman E. Susceptibility of the influence of weight on blood pressure in men versus women: lessons from a largescale study of young adults. Am J Hypertens. 2004;17(5 pt 1):404-408. doi: 10. 1016/j. amjhyper. 2003. 12. 012.
24. Sowers JR. Diabetes mellitus and cardiovascular disease in women. Arch Intern Med. 1998;158:617-621.
25. Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. 2002;162:1867-1872.
26. Grassi G, Dell'Oro R, Facchini A, Quarti Trevano F, Bolla GB, Mancia G. Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives. J Hypertens. 2004;22:2363-2369.
27. Tank J, Heusser K, Diedrich A, Hering D, Luft FC, Busjahn A, Narkiewicz K, Jordan J. Influences of gender on the interaction between sympathetic nerve traffic and central adiposity. J Clin Endocrinol Metab. 2008;93:4974-4978. doi: 10. 1210/jc. 2007-2820.
28. Hall JE, da Silva AA, do Carmo JM, Dubinion J, Hamza S, Munusamy S, Smith G, Stec DE. Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins. J Biol Chem. 2010;285:17271-17276. doi: 10. 1074/jbc. R110. 113175.
29. Straznicky NE, Grima MT, Eikelis N, Nestel PJ, Dawood T, Schlaich MP, Chopra R, Masuo K, Esler MD, Sari CI, Lambert GW, Lambert EA. The effects of weight loss versus weight loss maintenance on sympathetic nervous system activity and metabolic syndrome components. J Clin Endocrinol Metab. 2011;96:E503-E508. doi: 10. 1210/ jc. 2010-2204.
30. Lambert E, Straznicky N, Eikelis N, Esler M, Dawood T, Masuo K, Schlaich M, Lambert G. Gender differences in sympathetic nervous activity: influence of body mass and blood pressure. J Hypertens. 2007;25:1411-1419. doi: 10. 1097/HJH. 0b013e3281053af4.
31. Brooks VL, Shi Z, Holwerda SW, Fadel PJ. Obesity-induced increases in sympathetic nerve activity: sex matters. Auton Neurosci. 2015;187:18-26. doi: 10. 1016/j. autneu. 2014. 11. 006.
32. Abate NI, Mansour YH, Tuncel M, Arbique D, Chavoshan B, Kizilbash A, Howell-Stampley T, Vongpatanasin W, Victor RG. Overweight and sympathetic overactivity in black Americans. Hypertension. 2001;38: 379-383.
33. Hay M. Sex, the brain and hypertension: brain oestrogen receptors and high blood pressure risk factors. Clin Sci (Lond). 2016;130:9-18. doi: 10. 1042/CS20150654.
34. Briant LJ, Charkoudian N, Hart EC. Sympathetic regulation of blood pressure in normotension and hypertension: when sex matters. Exp Physiol. 2016;101:219-229. doi: 10. 1113/EP085368.
35. Lambert EA, Straznicky NE, Dixon JB, Lambert GW. Should the sympathetic nervous system be a target to improve cardiometabolic risk in obesity? Am J Physiol Heart Circ Physiol. 2015;309:H244-H258. doi: 10. 1152/ajpheart. 00096. 2015.
36. Jackson AS, Stanforth PR, Gagnon J, Rankinen T, Leon AS, Rao DC, Skinner JS, Bouchard C, Wilmore JH. The effect of sex, age and race on estimating percentage body fat from body mass index: the Heritage Family Study. Int J Obes Relat Metab Disord. 2002;26:789-796. doi: 10. 1038/sj. ijo. 0802006.
37. Enzi G, Gasparo M, Biondetti PR, Fiore D, Semisa M, Zurlo F. Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computed tomography. Am J Clin Nutr. 1986;44:739-746.
38. Krotkiewski M, Bjorntorp P, Sjostrom L, Smith U. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest. 1983;72:1150-1162. doi: 10. 1172/JCI111040.
39. Nishida C, Ko GT, Kumanyika S. Body fat distribution and noncommunicable diseases in populations: overview of the 2008 WHO Expert Consultation on Waist Circumference and Waist-Hip Ratio. Eur J Clin Nutr. 2010;64:2-5. doi: 10. 1038/ejcn. 2009. 139.
40. Alvarez GE, Beske SD, Ballard TP, Davy KP. Sympathetic neural activation in visceral obesity. Circulation. 2002;106:2533-2536.
41. Jones PP, Davy KP, Alexander S, Seals DR. Age-related increase in muscle sympathetic nerve activity is associated with abdominal adiposity. Am J Physiol. 1997;272(6 pt 1):E976-E980.
42. Alvarez GE, Ballard TP, Beske SD, Davy KP. Subcutaneous obesity is not associated with sympathetic neural activation. Am J Physiol Heart Circ Physiol. 2004;287:H414-H418. doi: 10. 1152/ajpheart. 01046. 2003.
43. Pardo JM. Massive hypertriglyceridemia complicating estrogen therapy. J Clin Endocrinol Metab. 1997;82:1649-1650.
44. Munoz J, Derstine A, Gower BA. Fat distribution and insulin sensitivity in postmenopausal women: influence of hormone replacement. Obes Res. 2002;10:424-431. doi: 10. 1038/oby. 2002. 59.
45. Reubinoff BE, Wurtman J, Rojansky N, Adler D, Stein P, Schenker JG, Brzezinski A. Effects of hormone replacement therapy on weight, body composition, fat distribution, and food intake in early postmenopausal women: a prospective study. Fertil Steril. 1995;64:963-968.
46. Trikudanathan S, Pedley A, Massaro JM, Hoffmann U, Seely EW, Murabito JM, Fox CS. Association of female reproductive factors with body composition: the Framingham Heart Study. J Clin Endocrinol Metab. 2013;98:236-244. doi: 10. 1210/jc. 2012-1785.
47. Espeland MA, Stefanick ML, Kritz-Silverstein D, Fineberg SE, Waclawiw MA, James MK, Greendale GA. Effect of postmenopausal hormone therapy on body weight and waist and hip girths. Postmenopausal Estrogen-Progestin Interventions Study Investigators. J Clin Endocrinol Metab. 1997;82:1549-1556. doi: 10. 1210/jcem. 82. 5. 3925.
48. Hogarth AJ, Graham LN, Corrigan JH, Deuchars J, Mary DA, Greenwood JP. Sympathetic nerve hyperactivity and its effect in postmenopausal women. J Hypertens. 2011;29:2167-2175. doi: 10. 1097/ HJH. 0b013e32834b8014.
49. Ozata M, Ozdemir IC, Licinio J. Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab. 1999;84:3686-3695. doi: 10. 1210/ jcem. 84. 10. 5999.
50. Greenfield JR, Miller JW, Keogh JM, Henning E, Satterwhite JH, Cameron GS, Astruc B, Mayer JP, Brage S, See TC, Lomas DJ, O'Rahilly S, Farooqi IS. Modulation of blood pressure by central melanocortinergic pathways. N Engl J Med. 2009;360:44-52. doi: 10. 1056/ NEJMoa0803085.
51. Belin de Chantemele EJ, Mintz JD, Rainey WE, Stepp DW. Impact of leptin-mediated sympatho-activation on cardiovascular function in obese mice. Hypertension. 2011;58:271-279.
52. Wang B, Chandrasekera PC, Pippin JJ. Leptin-and leptin receptor-deficient rodent models: relevance for human type 2 diabetes. Curr Diabetes Rev. 2014;10:131-145.
53. Isidori AM, Strollo F, More M, Caprio M, Aversa A, Moretti C, Frajese G, Riondino G, Fabbri A. Leptin and aging: correlation with endocrine changes in male and female healthy adult populations of different body weights. J Clin Endocrinol Metab. 2000;85:1954-1962. doi: 10. 1210/ jcem. 85. 5. 6572.
54. Azar ST, Salti I, Zantout MS, Shahine CH, Zalloua PA. Higher serum leptin level in women than in men with type 1 diabetes. Am J Med Sci. 2002;323:206-209.
55. Montague CT, Prins JB, Sanders L, Digby JE, O'Rahilly S. Depot-and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes. 1997;46:342-347.
56. Lonnqvist F, Wennlund A, Arner P. Relationship between circulating leptin and peripheral fat distribution in obese subjects. Int J Obes Relat Metab Disord. 1997;21:255-260.
57. Van Harmelen V, Reynisdottir S, Eriksson P, Thorne A, Hoffstedt J, Lonnqvist F, Arner P. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes. 1998;47:913-917.
58. Belin de Chantemele EJ, Muta K, Mintz J, Tremblay ML, Marrero MB, Fulton DJ, Stepp DW. Protein tyrosine phosphatase 1b, a major regulator of leptin-mediated control of cardiovascular function. Circulation. 2009;120:753-763.
59. Aizawa-Abe M, Ogawa Y, Masuzaki H, Ebihara K, Satoh N, Iwai H, Matsuoka N, Hayashi T, Hosoda K, Inoue G, Yoshimasa Y, Nakao K. Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest. 2000;105:1243-1252. doi: 10. 1172/JCI8341.
60. Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res. 2015;116:991-1006. doi: 10. 1161/CIRCRESAHA. 116. 305697.
61. Tao YX. The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology. Endocr Rev. 2010;31:506-543. doi: 10. 1210/ er. 2009-0037.
62. do Carmo JM, da Silva AA, Cai Z, Lin S, Dubinion JH, Hall JE. Control of blood pressure, appetite, and glucose by leptin in mice lacking leptin receptors in proopiomelanocortin neurons. Hypertension. 2011;57:918-926. doi: 10. 1161/HYPERTENSIONAHA. 110. 161349.
63. Rahmouni K, Haynes WG, Morgan DA, Mark AL. Selective resistance to central neural administration of leptin in agouti obese mice. Hypertension. 2002;39(2 pt 2):486-490.
64. Huby AC, Otvos L Jr, Belin de Chantemele EJ. Leptin induces hypertension and endothelial dysfunction via aldosterone-dependent mechanisms in obese female mice. Hypertension. 2016;67:1020-1028. doi: 10. 1161/ HYPERTENSIONAHA. 115. 06642.
65. Be?towski J. Gamma-MSH/MC3R natriuretic signaling system: the possible explanation for contrasting blood pressure effects of agouti mutation and melanocortin receptor knockout. Bioscience Hypotheses. 2008;1:243-247.
66. Huber DA, Schreihofer AM. Exaggerated sympathoexcitatory reflexes develop with changes in the rostral ventrolateral medulla in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol. 2016;311:R243-R253. doi: 10. 1152/ajpregu. 00085. 2016.
67. do Carmo JM, da Silva AA, Rushing JS, Hall JE. Activation of the central melanocortin system contributes to the increased arterial pressure in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol. 2012;302:R561-R567. doi: 10. 1152/ajpregu. 00392. 2011.
68. Zabolotny JM, Bence-Hanulec KK, Stricker-Krongrad A, Haj F, Wang Y, Minokoshi Y, Kim YB, Elmquist JK, Tartaglia LA, Kahn BB, Neel BG. PTP1B regulates leptin signal transduction in vivo. Dev Cell. 2002;2:489-495.
69. Quilliot D, Bohme P, Zannad F, Ziegler O. Sympathetic-leptin relationship in obesity: effect of weight loss. Metabolism. 2008;57:555-562. doi: 10. 1016/j. metabol. 2007. 11. 020.
70. Matsumoto T, Miyatsuji A, Miyawaki T, Yanagimoto Y, Moritani T. Potential association between endogenous leptin and sympatho-vagal activities in young obese Japanese women. Am J Hum Biol. 2003;15:8-15. doi: 10. 1002/ajhb. 10111.
71. Maranon R, Lima R, Spradley FT, do Carmo JM, Zhang H, Smith AD, Bui E, Thomas RL, Moulana M, Hall JE, Granger JP, Reckelhoff JF. Roles for the sympathetic nervous system, renal nerves, and CNS melanocortin-4 receptor in the elevated blood pressure in hyperandrogenemic female rats. Am J Physiol Regul Integr Comp Physiol. 2015;308:R708-R713. doi: 10. 1152/ajpregu. 00411. 2014.
72. da Silva AA, Spradley FT, Granger JP, Hall JE, do Carmo JM. Brainmediated antidiabetic, anorexic, and cardiovascular actions of leptin require melanocortin-4 receptor signaling. J Neurophysiol. 2015;113:2786-2791. doi: 10. 1152/jn. 00911. 2014.
73. Huby AC, Belin De Chantemele EJ. Reviving the use of aldosterone inhibitors in treating hypertension in obesity. Am J Physiol Regul Integr Comp Physiol. 2015;309:R1065-R1067. doi: 10. 1152/ajpregu. 00133. 2015.
74. Dinh Cat AN, Friederich-Persson M, White A, Touyz RM. Adipocytes, aldosterone and obesity-related hypertension. J Mol Endocrinol. 2016;57:F7-F21. doi: 10. 1530/JME-16-0025.
75. Goodfriend TL, Kelley DE, Goodpaster BH, Winters SJ. Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women. Obes Res. 1999;7:355-362.
76. de Haro Moraes C, Figueiredo VN, de Faria AP, Barbaro NR, Sabbatini AR, Quinaglia T, Ferreira-Melo SE, Martins LC, Demacq C, Junior HM. High-circulating leptin levels are associated with increased blood pressure in uncontrolled resistant hypertension. J Hum Hypertens. 2013;27:225-230. doi: 10. 1038/jhh. 2012. 29.
77. Huby AC, Antonova G, Groenendyk J, Gomez-Sanchez CE, Bollag WB, Filosa JA, Belin de Chantemele EJ. Adipocyte-derived hormone leptin is a direct regulator of aldosterone secretion, which promotes endothelial dysfunction and cardiac fibrosis. Circulation. 2015;132:2134-2145. doi: 10. 1161/CIRCULATIONAHA. 115. 018226.
78. Belin de Chantemele EJ, Ali MI, Mintz JD, Rainey WE, Tremblay ML, Fulton DJ, Stepp DW. Increasing peripheral insulin sensitivity by protein tyrosine phosphatase 1b deletion improves control of blood pressure in obesity. Hypertension. 2012;60:1273-1279.
79. Kanashiro-Takeuchi RM, Heidecker B, Lamirault G, Dharamsi JW, Hare JM. Sex-specific impact of aldosterone receptor antagonism on ventricular remodeling and gene expression after myocardial infarction. Clin Transl Sci. 2009;2:134-142. doi: 10. 1111/j. 1752-8062. 2009. 00094. x.
80. Khosla N, Kalaitzidis R, Bakris GL. Predictors of hyperkalemia risk following hypertension control with aldosterone blockade. Am J Nephrol. 2009;30:418-424. doi: 10. 1159/000237742.
81. Lima R, Wofford M, Reckelhoff JF. Hypertension in postmenopausal women. Curr Hypertens Rep. 2012;14:254-260. doi: 10. 1007/ s11906-012-0260-0.
82. Campbell KL, Foster-Schubert KE, Alfano CM, Wang CC, Wang CY, Duggan CR, Mason C, Imayama I, Kong A, Xiao L, Bain CE, Blackburn GL, Stanczyk FZ, McTiernan A. Reduced-calorie dietary weight loss, exercise, and sex hormones in postmenopausal women: randomized controlled trial. J Clin Oncol. 2012;30:2314-2326. doi: 10. 1200/ JCO. 2011. 37. 9792.
83. Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev. 2002;11:1531-1543.
84. Ahima RS, Dushay J, Flier SN, Prabakaran D, Flier JS. Leptin accelerates the onset of puberty in normal female mice. J Clin Invest. 1997;99:391-395. doi: 10. 1172/JCI119172.
85. Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice AM, Hughes IA, McCamish MA, O'Rahilly S. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med. 1999;341:879-884. doi: 10. 1056/NEJM199909163411204.
86. Sagawa N, Yura S, Itoh H, Mise H, Kakui K, Korita D, Takemura M, Nuamah MA, Ogawa Y, Masuzaki H, Nakao K, Fujii S. Role of leptin in pregnancy-a review. Placenta. 2002;23(suppl A):S80-S86. doi: 10. 1053/ plac. 2002. 0814.
87. Riad-Gabriel MG, Jinagouda SD, Sharma A, Boyadjian R, Saad MF. Changes in plasma leptin during the menstrual cycle. Eur J Endocrinol. 1998;139:528-531.
88. Shi Z, Brooks VL. Leptin differentially increases sympathetic nerve activity and its baroreflex regulation in female rats: role of oestrogen. J Physiol. 2015;593:1633-1647. doi: 10. 1113/jphysiol. 2014. 284638.
89. Fallah S, Sanjary Pour M, Rabbani Chadegani A, Korani M. Adiponectin, leptin and lipid profiles evaluation in oral contraceptive pill consumers. Arch Gynecol Obstet. 2012;285:1747-1752. doi: 10. 1007/ s00404-011-2192-3.
90. Li W, Xu L, Chen Y, Mu L, Cheng M, Xu W, Zhuang J, Zhang J. Effect of estrodiol on leptin receptors expression in regulating fat distribution and adipocyte genesis. Gynecol Endocrinol. 2016;32:464-468. doi: 10. 3109/09513590. 2015. 1130810.
91. Navarro G, Allard C, Xu W, Mauvais-Jarvis F. The role of androgens in metabolism, obesity, and diabetes in males and females. Obesity (Silver Spring). 2015;23:713-719. doi: 10. 1002/oby. 21033.
92. Gorzelniak K, Engeli S, Janke J, Luft FC, Sharma AM. Hormonal regulation of the human adipose-tissue renin-angiotensin system: relationship to obesity and hypertension. J Hypertens. 2002;20:965-973.
93. Thethi T, Kamiyama M, Kobori H. The link between the renin-angiotensin-aldosterone system and renal injury in obesity and the metabolic syndrome. Curr Hypertens Rep. 2012;14:160-169. doi: 10. 1007/ s11906-012-0245-z.
94. Littlejohn NK, Grobe JL. Opposing tissue-specific roles of angiotensin in the pathogenesis of obesity, and implications for obesity-related hypertension. Am J Physiol Regul Integr Comp Physiol. 2015;309:R1463-R1473. doi: 10. 1152/ajpregu. 00224. 2015.
95. Taylor LE, Sullivan JC. Sex differences in obesity-induced hypertension and vascular dysfunction: a protective role for estrogen in adipose tissue inflammation? Am J Physiol Regul Integr Comp Physiol. 2016;311:R714-R720. doi: 10. 1152/ajpregu. 00202. 2016.
96. Kim JM, Kim TH, Lee HH, Lee SH, Wang T. Postmenopausal hypertension and sodium sensitivity. J Menopausal Med. 2014;20:1-6. doi: 10. 6118/jmm. 2014. 20. 1. 1.
97. Pechere-Bertschi A, Burnier M. Female sex hormones, salt, and blood pressure regulation. Am J Hypertens. 2004;17:994-1001. doi: 10. 1016/j. amjhyper. 2004. 08. 009.
98. Sullivan JC. Sex and the renin-angiotensin system: inequality between the sexes in response to RAS stimulation and inhibition. Am J Physiol Regul Integr Comp Physiol. 2008;294:R1220-R1226. doi: 10. 1152/ ajpregu. 00864. 2007.
99. Gupte M, Thatcher SE, Boustany-Kari CM, Shoemaker R, Yiannikouris F, Zhang X, Karounos M, Cassis LA. Angiotensin converting enzyme 2 contributes to sex differences in the development of obesity hypertension in C57BL/6 mice. Arterioscler Thromb Vasc Biol. 2012;32:1392-1399. doi: 10. 1161/ATVBAHA. 112. 248559.
100. Wang Y, Shoemaker R, Thatcher SE, Batifoulier-Yiannikouris F, English VL, Cassis LA. Administration of 17?-estradiol to ovariectomized obese female mice reverses obesity-hypertension through an ACE2-dependent mechanism. Am J Physiol Endocrinol Metab. 2015;308:E1066-E1075. doi: 10. 1152/ajpendo. 00030. 2015.
101. Reisin E, Weir MR, Falkner B, Hutchinson HG, Anzalone DA, Tuck ML. Lisinopril versus hydrochlorothiazide in obese hypertensive patients: a multicenter placebo-controlled trial. Treatment in Obese Patients With Hypertension (TROPHY) Study Group. Hypertension. 1997;30(1 pt 1):140-145.
102. Wofford MR, Anderson DC Jr, Brown CA, Jones DW, Miller ME, Hall JE. Antihypertensive effect of alpha-and beta-adrenergic blockade in obese and lean hypertensive subjects. Am J Hypertens. 2001;14(7 pt 1):694-698.
103. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507-520. doi: 10. 1001/jama. 2013. 284427.